Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
440
Trial Sponsor
Clinical Trial Start Date
2009
0Primary Completion Date
2009
0Study Completion Date
2009
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Interventional Trial Phase
Phase 10
Official Name
A Phase Ib, Randomized, Open-Label, Multi-Center, 4-Week Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITCA 650 in Subjects With Type 2 Diabetes Mellitus0
Last Updated
May 17, 2013
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
ITCA 650 (exenatide in DUROS)0
Study summary
evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
